Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mucosal Immune Response to MenB OMV Vaccine
NCT00774384Phase 2Completed
- Sponsor
- University Hospitals Bristol and Weston NHS Foundation Trust
- Start
- Sep 2009
- Primary completion
- Nov 2011
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of NZ MenB OMV vaccine in meningococcal disease, sponsored by University Hospitals Bristol and Weston NHS Foundation Trust. Started Sep 2009; status: completed.
02
Drugs
NZ MenB OMV vaccine
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on NCT00774384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00774384.